Doximity (NYSE:DOCS) Upgraded at Canaccord Genuity Group

Canaccord Genuity Group upgraded shares of Doximity (NYSE:DOCS) from a hold rating to a buy rating in a research note released on Monday morning, MarketBeat.com reports. They currently have $34.00 price objective on the stock.

Several other brokerages have also recently commented on DOCS. The Goldman Sachs Group raised shares of Doximity from a “strong sell” rating to a “hold” rating in a research report on Friday, January 9th. Needham & Company LLC upgraded Doximity to a “moderate buy” rating in a research note on Friday, February 6th. Wells Fargo & Company raised Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 target price on the stock in a report on Tuesday, January 20th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Doximity in a research report on Wednesday, December 24th. Finally, Zacks Research raised Doximity from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 26th. Three investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $44.50.

Doximity Stock Down 4.6%

NYSE DOCS opened at $25.99 on Monday. The company has a market cap of $4.89 billion, a P/E ratio of 21.66, a price-to-earnings-growth ratio of 1.53 and a beta of 1.39. Doximity has a 12 month low of $23.66 and a 12 month high of $79.97. The company’s fifty day moving average is $40.47.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.